CD4 and lymphoma: One HIV-positive SARS-CoV-2 naive donor with a low CD4 T cell count of 40 cells/μL on cART, and one individual with relapsed lymphoma, both had no detectable humoral and cellular responses after 2 or 3 doses of mRNA vaccine.